When your PSA starts to rise after you have received primary treatment you need to be concerned that your prostate cancer has reoccurred. The first indicator of recurrent prostate cancer is a detectable level of prostate-specific antigen (PSA). Research has demonstrated that PSA doubling time is a reliable tool to distinguish which cancers pose a [...]
"It doesn't matter who my father was; it matters who I remember he was. " -Anne Sexton
Press Release: Dendreon Corporation (Nasdaq: DNDN) announced the following data presentations taking place at the American Urological Association's (AUA) Annual Meeting in Chicago, as well as a Dendreon-sponsored IMPACT data webcast conference call: (for those of us who will be unable to attend the session at AUA in Chicago) April 28, 2009, 2:20 p.m. CDT-"A [...]
As we age, especially for those of us who have advanced and recurrent prostate cancer we need to "put our affairs in order". This includes making sure we have a valid Will, have established any trusts that our spouses, partners, children and grandchildren might need, signed a health care proxy and appointed an individual with [...]
The American Association of Cancer Researchers (AACR) is in the midst of its annual scientific research meeting in Denver Colorado. As interesting prostate cancer specific information becomes available I will try and share the news. One of the biggest concerns we face in prostate cancer is in deciding when a cancer needs to be treated. [...]